Evidence map›Paper›PMID 40918692›Full record

ArticleNEJM AI2025

AI-Powered Diabetes Precision Health: From Data to Action.

Jia Nie, Carol Haft, Ashley Xia, Xujing Wang

Abstract read
In one paragraph

Article in NEJM AI, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jia NieDivision of Diabetes, Endocrinology, and Metabolic Diseases, the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.ORCID 0000-0001-9085-7224
Carol HaftDivision of Diabetes, Endocrinology, and Metabolic Diseases, the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.ORCID 0009-0002-5365-3251
Ashley XiaDivision of Diabetes, Endocrinology, and Metabolic Diseases, the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.ORCID 0000-0002-9534-8506
Xujing WangDivision of Diabetes, Endocrinology, and Metabolic Diseases, the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.ORCID 0000-0001-9668-8812

Funding

Intramural NIH HHS Z99 DK999999
6 · The paper itself

Abstract

Diabetes has become a major public health challenge due to its high prevalence and chronic nature, with many individuals managing the condition for decades. The vast heterogeneity in diabetes necessitates personalized approaches to its prevention, diagnosis, treatment, and prognosis. Recently, the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health convened experts from the fields of diabetes and AI to identify and discuss existing gaps, as well as potentially transformative opportunities and actionable items enabled by recent advancements in AI. One prominent theme that has emerged from this discussion was the considerable potential of AI in Diabetes Precision Health, a field that warrants greater attention. The purpose of this article is to describe the opportunities and challenges identified during the workshop and outline potential strategies recommended by workshop attendees to advance this promising field.

Identifiers

PMID40918692
PMCPMC12412894

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.